253 related articles for article (PubMed ID: 10976894)
1. Local recurrence after mastectomy and adjuvant CMF: implications for adjuvant radiation therapy.
Rangan AM; Ahern V; Yip D; Boyages J
Aust N Z J Surg; 2000 Sep; 70(9):649-55. PubMed ID: 10976894
[TBL] [Abstract][Full Text] [Related]
2. Extracapsular axillary node extension in patients receiving adjuvant systemic therapy: an indication for radiotherapy?
Fisher BJ; Perera FE; Cooke AL; Opeitum A; Dar AR; Venkatesan VM; Stitt L; Radwan JS
Int J Radiat Oncol Biol Phys; 1997 Jun; 38(3):551-9. PubMed ID: 9231679
[TBL] [Abstract][Full Text] [Related]
3. Long-term follow-up of axillary node-positive breast cancer patients receiving adjuvant systemic therapy alone: patterns of recurrence.
Fisher BJ; Perera FE; Cooke AL; Opeitum A; Venkatesan V; Dar AR; Stitt L
Int J Radiat Oncol Biol Phys; 1997 Jun; 38(3):541-50. PubMed ID: 9231678
[TBL] [Abstract][Full Text] [Related]
4. The importance of local-regional radiotherapy with conventional or high-dose chemotherapy in the management of breast cancer patients with > or = 10 positive axillary nodes.
Jabro G; Wazer DE; Ruthazer R; Lum R; Sklar N; Goldman D; Enegess D; Erban J
Int J Radiat Oncol Biol Phys; 1999 May; 44(2):273-80. PubMed ID: 10760419
[TBL] [Abstract][Full Text] [Related]
5. Combined chemotherapy and radiotherapy for patients with breast cancer and extensive nodal involvement.
Ung O; Langlands AO; Barraclough B; Boyages J
J Clin Oncol; 1995 Feb; 13(2):435-43. PubMed ID: 7844606
[TBL] [Abstract][Full Text] [Related]
6. Locoregional failure of postmastectomy patients with 1-3 positive axillary lymph nodes without adjuvant radiotherapy.
Cheng JC; Chen CM; Liu MC; Tsou MH; Yang PS; Jian JJ; Cheng SH; Tsai SY; Leu SY; Huang AT
Int J Radiat Oncol Biol Phys; 2002 Mar; 52(4):980-8. PubMed ID: 11958892
[TBL] [Abstract][Full Text] [Related]
7. The presence of proliferative breast disease with atypia does not significantly influence outcome in early-stage invasive breast cancer treated with conservative surgery and radiation.
Fowble B; Hanlon AL; Patchefsky A; Freedman G; Hoffman JP; Sigurdson ER; Goldstein LJ
Int J Radiat Oncol Biol Phys; 1998 Aug; 42(1):105-15. PubMed ID: 9747827
[TBL] [Abstract][Full Text] [Related]
8. Natural history of more than 20 years of node-positive primary breast carcinoma treated with cyclophosphamide, methotrexate, and fluorouracil-based adjuvant chemotherapy: a study by the Cancer and Leukemia Group B.
Weiss RB; Woolf SH; Demakos E; Holland JF; Berry DA; Falkson G; Cirrincione CT; Robbins A; Bothun S; Henderson IC; Norton L;
J Clin Oncol; 2003 May; 21(9):1825-35. PubMed ID: 12721260
[TBL] [Abstract][Full Text] [Related]
9. The 5-year results of a randomized trial of adjuvant radiation therapy after chemotherapy in breast cancer patients treated with mastectomy.
Griem KL; Henderson IC; Gelman R; Ascoli D; Silver B; Recht A; Goodman RL; Hellman S; Harris JR
J Clin Oncol; 1987 Oct; 5(10):1546-55. PubMed ID: 3309196
[TBL] [Abstract][Full Text] [Related]
10. The role of radiotherapy in patients undergoing mastectomy for carcinoma of the breast.
Fernando IN
Clin Oncol (R Coll Radiol); 2000; 12(3):158-65. PubMed ID: 10942332
[TBL] [Abstract][Full Text] [Related]
11. Identification of patients with node-negative, triple-negative breast cancer who benefit from adjuvant cyclophosphamide, methotrexate, and 5-fluorouracil chemotherapy.
Wu CE; Chen SC; Lin YC; Lo YF; Hsueh S; Chang HK
Anticancer Res; 2014 Mar; 34(3):1301-6. PubMed ID: 24596377
[TBL] [Abstract][Full Text] [Related]
12. Long-term outcome after postmastectomy radiation therapy for breast cancer patients at high risk for local-regional recurrence.
Metz JM; Schultz DJ; Fox K; Glick J; Solin LJ
Cancer J Sci Am; 1999; 5(2):77-83. PubMed ID: 10198729
[TBL] [Abstract][Full Text] [Related]
13. Simultaneous adjuvant radiotherapy and chemotherapy for stage I and II breast cancer.
Lamb D; Atkinson C; Joseph D; O'Brien P; Ackland S; Bonaventura A; Dady P; Hamilton C; Spry N; Stewart J; Denham J
Australas Radiol; 1999 May; 43(2):220-6. PubMed ID: 10901906
[TBL] [Abstract][Full Text] [Related]
14. Postoperative radiotherapy in high-risk premenopausal women with breast cancer who receive adjuvant chemotherapy. Danish Breast Cancer Cooperative Group 82b Trial.
Overgaard M; Hansen PS; Overgaard J; Rose C; Andersson M; Bach F; Kjaer M; Gadeberg CC; Mouridsen HT; Jensen MB; Zedeler K
N Engl J Med; 1997 Oct; 337(14):949-55. PubMed ID: 9395428
[TBL] [Abstract][Full Text] [Related]
15. Local-regional failure in patients treated with adjuvant chemotherapy for breast cancer.
Stefanik D; Goldberg R; Byrne P; Smith F; Ueno W; Smith L; Bachenheimer L; Beiser C; Dritschilo A
J Clin Oncol; 1985 May; 3(5):660-5. PubMed ID: 3998783
[TBL] [Abstract][Full Text] [Related]
16. Incidence and time of occurrence of regional recurrence in stage I-II breast cancer: value of adjuvant irradiation.
Fodor J; Toth J; Major T; Polgar C; Nemeth G
Int J Radiat Oncol Biol Phys; 1999 May; 44(2):281-7. PubMed ID: 10760420
[TBL] [Abstract][Full Text] [Related]
17. T1-T2 breast cancer with four or more positive axillary lymph nodes: adjuvant locoregional radiotherapy with high-dose or standard-dose chemotherapy. Results of an observational study.
Perrucci E; Aristei C; De Angelis V; Anselmo P; Mascioni F; Gori S; Frattegiani A; Latini P
Tumori; 2004; 90(4):379-86. PubMed ID: 15510979
[TBL] [Abstract][Full Text] [Related]
18. Comparison of adjuvant chemotherapy with methotrexate and fluorouracil with and without cyclophosphamide in breast cancer patients with one to three positive axillary lymph nodes.
Shapiro CL; Gelman RS; Hayes DF; Osteen R; Obando A; Canellos GP; Frei E; Henderson IC
J Natl Cancer Inst; 1993 May; 85(10):812-7. PubMed ID: 8487326
[TBL] [Abstract][Full Text] [Related]
19. Postmastectomy radiotherapy and concomitant adjuvant chemotherapy versus adjuvant chemotherapy alone in premenopausal breast cancer patients with positive axillary nodes.
Micheletti E; La Face B; Huscher A; Catalano G; Ambrosi E; Marini G; Simoncini E
Tumori; 1998; 84(6):652-8. PubMed ID: 10080670
[TBL] [Abstract][Full Text] [Related]
20. Loco-regional recurrences after mastectomy in breast cancer: prognostic factors and implications for postoperative irradiation.
Jager JJ; Volovics L; Schouten LJ; de Jong JM; Hupperets PS; von Meyenfeldt MF; Schutte B; Blijham GH
Radiother Oncol; 1999 Mar; 50(3):267-75. PubMed ID: 10392812
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
